Tecan Group AG (0QLN.L)

CHF 162.88

(3.52%)

Revenue Summary of Tecan Group AG

  • Tecan Group AG's latest annual revenue in 2023 was 1.07 Billion CHF , down -6.11% from previous year.
  • Tecan Group AG's latest quarterly revenue in 2024 Q2 was 467.15 Million CHF , down 0.0% from previous quarter.
  • Tecan Group AG reported a annual revenue of 1.14 Billion CHF in annual revenue 2022, up 20.88% from previous year.
  • Tecan Group AG reported a annual revenue of 946.62 Million CHF in annual revenue 2021, up 29.52% from previous year.
  • Tecan Group AG reported a quarterly revenue of 541.49 Million CHF for 2023 Q2, down 0.0% from previous quarter.
  • Tecan Group AG reported a quarterly revenue of 1.07 Billion CHF for 2023 FY, down -6.11% from previous quarter.

Annual Revenue Chart of Tecan Group AG (2023 - 2002)

Historical Annual Revenue of Tecan Group AG (2023 - 2002)

Year Revenue Revenue Growth
2023 1.07 Billion CHF -6.11%
2022 1.14 Billion CHF 20.88%
2021 946.62 Million CHF 29.52%
2020 730.87 Million CHF 14.77%
2019 636.81 Million CHF 7.25%
2018 593.79 Million CHF 8.25%
2017 548.55 Million CHF 8.36%
2016 506.22 Million CHF 14.97%
2015 440.29 Million CHF 10.21%
2014 399.51 Million CHF 2.89%
2013 388.29 Million CHF -0.72%
2012 391.1 Million CHF 3.75%
2011 376.97 Million CHF 1.73%
2010 370.54 Million CHF -5.45%
2009 391.91 Million CHF -1.04%
2008 396.04 Million CHF -4.43%
2007 414.4 Million CHF 2.09%
2006 405.92 Million CHF 17.69%
2005 344.9 Million CHF 20.6%
2004 285.97 Million CHF -8.23%
2003 311.6 Million CHF -6.19%
2002 332.18 Million CHF 0.0%

Peer Revenue Comparison of Tecan Group AG

Name Revenue Revenue Difference
Relief Therapeutics Holding AG 6.03 Million CHF -17708.487%
Santhera Pharmaceuticals Holding AG 103.41 Million CHF -938.917%
Basilea Pharmaceutica AG 157.63 Million CHF -581.57%
Bachem Holding AG 577.31 Million CHF -86.1%
Siegfried Holding AG 1.27 Billion CHF 15.502%
Molecular Partners AG 7.03 Million CHF -15165.502%